Atherosclerotic Renal Artery Stenosis: Medical Therapy Alone or in Combination with Revascularization?

Kendrick J. , Chonchol M. Renal artery stenosis and chronic ischemic nephropathy: epidemiology and diagnosis. Adv Chronic Kidney Dis. 2008; 15(4): 355–362.

Karagiannis A. , Mikhailidis D.P. , Athyros V.G. , Harsoulis F. Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer. 2007; 14(4): 935–956.

Karagiannis A. , Tziomalos K. , Kakafika A.I. , Athyros V.G. , Harsoulis F. , Mikhailidis D.P. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas. Endocr Relat Cancer. 2008; 15(3): 693–700.

Safian R.D. , Textor S.C. Renal-artery stenosis. N Engl J Med. 2001; 344(6): 431–442.

Conlon P.J. , Little M.A. , Pieper K. , Mark D.B. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001; 60(4): 1490–1497.

Kalra P.A. , Guo H. , Kausz A.T. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005; 68(1): 293–301.

Mui K.W. , Sleeswijk M. , van den Hout H. , van Baal J. , Navis G. , Woittiez A.J. Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol. 2006; 17(7): 2069–2074.

Leertouwer T.C. , Pattynama P.M. , van den Berg-Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int. 2001; 59(4): 1480–1483.

Alcázar J.M. , Marín R. , Gómez-Campderá F. , Orte L. , Rodríguez-Jornet A. , Mora-Macía J. Clinical characteristics of ischaemic renal disease. Nephrol Dial Transplant. 2001; 16(suppl l): 74–77.

Caps M.T. , Perissinotto C. , Zierler R.E. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998; 98(25): 2866–2872.

Caps M.T. , Zierler R.E. , Polissar N.L. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998; 53(3): 735–742.

Levin A. , Linas S. , Luft F.C. , Chapman A.B. , Textor S. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol. 2007; 27(2): 212–220.

Paraskevas K.I. , Hamilton G. , Cross J.M. , Mikhailidis D.P. Atherosclerotic renal artery stenosis: association with emerging vascular risk factors. Nephron Clin Pract. 2008; 108(1): 56–66.

Karagiannis A. , Douma S. , Vogiatzis K. The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension. Acta Cardiol. 1994; 49(5): 425–434.

Zamboulis C. , Karagiannis A. , Douma S. Changes of plasma noradrenaline levels in the renal and systemic circulation after successful percutaneous transluminal angioplasty in renovascular hypertension. Clin Exp Hypertens A. 1989; 11(suppl l): 449–458.

Petersson M.J. , Rundqvist B. , Johansson M. Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens. 2002; 20(6): 1181–1187.

Minuz P. , Patrignani P. , Gaino S. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation. 2002; 106(22): 2800–2805.

Higashi Y. , Sasaki S. , Nakagawa K. , Matsuura H. , Oshima T. , Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002; 346(25): 1954–1962.

Losito A. , Fagugli R.M. , Zampi I. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens. 1996; 9(11): 1062–1067.

Iantorno M. , Pola R. , Schinzari F. Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension. Cardiology. 2003; 100(3): 114–119.

Butler A.M. Chronic pyelonephritis and arterial hypertension. J Clin Invest. 1937; 16(6): 889–897.

Hunt J.C. , Strong C.G. Renovascular hypertension. Mechanisms, natural history and treatment. Am J Cardiol. 1973; 32(4): 562–574.

Lazarus J.M. , Hampers C.L. , Bennett A.H. , Vandam L.D. , Merrill J.P. Urgent bilateral nephrectomy for severe hypertension. Ann Intern Med. 1972; 76(5): 733–739.

Bennett A.H. , Lazarus J.M. Bilateral nephrectomy performed on an emergency basis for life-threatening malignant hypertension. Surg Gynecol Obstet. 1973; 137(3): 451–452.

Hackam D.G. , Spence J.D. , Garg A.X. , Textor S.C. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension. 2007; 50(6): 998–1003.

Textor S.C. ACE inhibitors in renovascular hypertension. Cardiovasc Drugs Ther. 1990; 4(1): 229–235.

van de Ven P.J. , Beutler J.J. , Kaatee R. , Beek F.J. , Mali W.P. , Koomans H.A. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 1998; 53(4): 986–993.

Athyros V.G. , Mikhailidis D.P. , Liberopoulos E.N. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant. 2007; 22(1): 118–127.

Shepherd J. , Kastelein J.J. , Bittner V. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007; 2(6): 1131–1139.

Collins R. , Armitage J. , Parish S. , Sleigh P. , Peto R. , for the Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003; 361(9374): 2005–2016.

Youssef F. , Gupta P. , Seifalian A.M. , Myint F. , Mikhailidis D.P. , Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology. 2004; 55(1): 53–62.

Alnaeb M.E. , Youssef F. , Mikhailidis D.P. , Hamilton G. Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease. Angiology. 2006; 57(1): 65–71.

Silva V.S. , Martin L.C. , Franco R.J. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens. 2008; 21(10): 1163–1168.

Middleton J.P. Ischemic disease of the kidney: how and why to consider revascularization. J Nephrol. 1998; 11(3): 123–136.

Steinbach F. , Novick A.C. , Campbell S. , Dykstra D. Long-term survival after surgical revascularization for atherosclerotic renal artery disease. J Urol. 1997; 158(1): 38–41.

Bonelli F.S. , McKusick M.A. , Textor S.C. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc. 1995; 70(11): 1041–1052.

Karagiannis A. , Douma S. , Voyiatzis K. Percutaneous transluminal renal angioplasty in patients with renovascular hypertension: long-term results. Hypertens Res. 1995; 18(1): 27–31.

Jensen G. , Zachrisson B.F. , Delin K. , Volkmann R. , Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int. 1995; 48(6): 1936–1945.

von Knorring J. , Edgren J. , Lepäntalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiol. 1996; 37(1): 36–40.

Weibull H. , Bergqvist D. , Bergentz S.E. , Jonsson K. , Hulthén L. , Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg. 1993; 18(5): 841–850.

Davidson R.A. , Barri Y. , Wilcox C.S. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis. 1996; 28(3): 334–338.

Mahler F. , Triller J. , Weidmann P. , Nachbur B. Complications in percutaneous transluminal dilatation of renal arteries. Nephron. 1986; 44(suppl l): 60–63.

Plouin P.F. , Darné B. , Chatellier G. Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension. 1993; 21(1): 89–96.

Rees C.R. , Palmaz J.C. , Becker G.J. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology. 1991; 181(2): 507–514.

Dorros G. , Prince C. , Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Catheter Cardiovasc Diagn. 1993; 29(3): 191–198.

van de Ven P.J. , Kaatee R. , Beutler J.J. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999; 353(9149): 282–286.

Hirsch A.T. , Haskal Z.J. , Hertzer N.R. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006; 113(11): e463–e654.

Losinno F. , Zuccalà A. , Busato F. , Zucchelli P. Renal artery angioplasty for renovascular hypertension and preservation of renal function: long-term angiographic and clinical follow-up. AJR Am J Roentgenol. 1994; 162(4): 853–857.

Airoldi F. , Palatresi S. , Marana I. Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens. 2000; 13(11): 1210–1207.

Dorros G. , Jaff M. , Mathiak L. , He T. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1, 058 successful patients. Catheter Cardiovasc Interv. 2002; 55(2): 182–188.

Leertouwer T.C. , Derkx F.H. , Pattynama P.M. , Deinum J. , van Dijk L.C. , Schalekamp M.A. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int. 2002; 62(2): 574–579.

Murphy T.P. , Soares G. , Kim M. Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996–2000. AJR Am J Roentgenol. 2004; 183(3): 561–568.

Webster J. , Marshall F. , Abdalla M. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Human Hypertens. 1998; 12(5): 329–335.

Plouin P.F. , Chatellier G. , Darné B. , Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998; 31(3): 823–829.

van Jaarsveld B.C. , Krijnen P. , Pieterman H. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000; 342(14): 1007–1014.

Textor S.C. , Wilcox C.S. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med. 2001; 52: 421–442.

Mistry S. , Ives N. , Harding J. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens. 2007; 21(7): 511–515.

Angioplasty and stent for renal artery lesions. www.astral.bham.ac.uk. Accessed February 1st, 2009.

Bax L. , Mali W.P. , Buskens E. The benefit of STent placement and blood pressure and lipid-Iowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. J Nephrol. 2003; 16(6): 807–812.

Cooper C.J. , Murphy T.P. , Matsumoto A. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006; 152(1): 59–66.